HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical and hemodynamic efficiency of dilatrend treatment in patients with dilatation cardiomyopathy].

Abstract
In present study we describe the clinical case of successful treatment of dilatation cardiomyophaty based on dilatrend using. 32 years old patient with acute heart failure and rhythm dysfunction was active user of alcohol since 1993. At the beginning of treatment 25 mg of dilatrend twice per day was used. The dose was increased monthly by 2.5 mg. After 4 months of treatment clinical signs of disease were eliminated at the daily dose 50 mg of dilatrend. In order to recover from arrhythmia on the seventh month of treatment cardioversion was successfully carried out. As it follows from our experience dilatrend is very effective for treatment of dilatative cardiomyopathy of alcoholic genesis.
AuthorsM I Dzhaniashvili, N G Chanturiia, G A Panchulidze
JournalGeorgian medical news (Georgian Med News) Issue 129 Pg. 60-3 (Dec 2005) ISSN: 1512-0112 [Print] Georgia (Republic)
PMID16444033 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Carbazoles
  • Propanolamines
  • Vasodilator Agents
  • Carvedilol
Topics
  • Adult
  • Carbazoles (therapeutic use)
  • Cardiomyopathy, Dilated (diagnosis, drug therapy, physiopathology)
  • Carvedilol
  • Electrocardiography
  • Hemodynamics (physiology)
  • Humans
  • Male
  • Propanolamines (therapeutic use)
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: